HomeOXBDF • OTCMKTS
add
Oxford BioMedica plc
Nakaraang pagsara
$3.72
Sakop ng taon
$2.09 - $5.80
Market cap
345.19M GBP
Average na Volume
130.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | 23.24M | -38.81% |
Gastos sa pagpapatakbo | 26.27M | -19.77% |
Net na kita | -54.77M | -701.04% |
Net profit margin | -235.67 | -1,209.28% |
Kita sa bawat share | — | — |
EBITDA | -13.69M | 2.95% |
Aktuwal na % ng binabayarang buwis | 3.44% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 103.72M | -26.59% |
Kabuuang asset | 252.34M | -45.16% |
Kabuuang sagutin | 174.51M | -22.09% |
Kabuuang equity | 77.83M | — |
Natitirang share | 96.80M | — |
Presyo para makapag-book | 4.89 | — |
Return on assets | -17.22% | — |
Return on capital | -22.95% | — |
Cash Flow
Net change in cash
| (GBP) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -54.77M | -701.04% |
Cash mula sa mga operasyon | -11.55M | -294.21% |
Cash mula sa pag-invest | 511.50K | -97.90% |
Cash mula sa financing | -2.90M | 84.69% |
Net change in cash | -12.86M | -212.90% |
Malayang cash flow | -8.59M | -22.05% |
Tungkol
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Itinatag
1995
Website
Mga Empleyado
703
